このエントリーをはてなブックマークに追加
ID 40040
フルテキストURL
Thumnail 122_107.pdf 743 KB
タイトル(別表記)
Analysis of fecal DNA methylation to detect gastrointestinal neoplasia
著者
永坂 岳司 岡山大学大学院医歯薬総合研究科 消化器・腫瘍外科学
田中 紀章 鳥取市立病院
孫 冬生 岡山大学大学院医歯薬総合研究科 消化器・腫瘍外科学
猶本 良夫 川崎医科大学附属病院 外科
松原 長秀 兵庫医科大学 外科
八木 孝仁 岡山大学大学院医歯薬総合研究科 消化器・腫瘍外科学
藤原 俊義 岡山大学大学院医歯薬総合研究科 消化器・腫瘍外科学
キーワード
methylation
stool
colorectal cancer
gastric cancer
screening
備考
平成22年度岡山医学会賞(林原賞)受賞論文 (The 2009 Okayama Medical Association Awards)
発行日
2010-08-02
出版物タイトル
岡山医学会雑誌
出版物タイトル(別表記)
Journal of Okayama Medical Association
122巻
2号
出版者
岡山医学会
出版者(別表記)
Okayama Medical Association
開始ページ
107
終了ページ
112
ISSN
0030-1558
NCID
AN00032489
資料タイプ
学術雑誌論文
関連URL
http://www.okayama-u.ac.jp/user/oma/
参考文献
1) Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F : Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med (1993) 328, 1365-1371.
2) Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM : Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet (1996) 348, 1472-1477.
3) Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O : Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet (1996) 348, 1467-1471.
4) Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y : A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology (2005) 129, 422-428.
5) Osborn NK, Ahlquist DA : Stool screening for colorectal cancer : molecular approaches. Gastroenterology (2005) 128, 192-206.
6) Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B : Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (1992) 256, 102-105.
7) Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, Thibodeau SN, Shuber AP : Colorectal cancer screening by detection of altered human DNA in stool : feasibility of a multitarget assay panel. Gastroenterology (2000) 119, 1219-1227.
8) Müller HM, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M, Mühlthaler M, Ofner D, Margreiter R, Widschwendter M : Methylation changes in faecal DNA : a marker for colorectal cancer screening? Lancet (2004) 363, 1283-1285.
9) Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME : Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med (2004) 351, 2704-2714.
10) Zou H, Harrington JJ, Klatt KK, Ahlquist DA : A sensitive method to quantify human long DNA in stool : relevance to colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (2006) 15, 1115-1119.
11) Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC 3rd, Sontag S, Johnson D, Markowitz S, Paszat L, Berger BM : A simplified, noninvasive stool DNA test for colorectal cancer detection. The American journal of gastroenterology (2008) 103, 2862-2870.
12) Nagasaka T, Tanaka N, Cullings HM, Sun DS, Sasamoto H, Uchida T, Koi M, Nishida N, Naomoto Y, Boland CR, Matsubara N, Goel A : Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. J Natl Cancer Inst (2009) 101, 1244-1258.
13) Nagasaka T, Koi M, Kloor M, Gebert J, Vilkin A, Nishida N, Shin SK, Sasamoto H, Tanaka N, Matsubara N, Boland CR, Goel A : Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. Gastroenterology (2008) 134, 1950-1960, 1960e1.
14) Akino K, Toyota M, Suzuki H, Mita H, Sasaki Y, Ohe-Toyota M, Issa JP, Hinoda Y, Imai K, Tokino T : The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology (2005) 129, 156-169.
15) Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M, Tokino T, et al. : Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 36, 417-422.
16) Nojima M, Suzuki H, Toyota M, Watanabe Y, Maruyama R, Sasaki S, Sasaki Y, Mita H, Nishikawa N, Yamaguchi K, Hirata K, Itoh F, et al. : Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene (2007) 26, 4699-4713.
17) Endoh M, Tamura G, Honda T, Homma N, Terashima M, Nishizuka S, Motoyama T : RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer. Br J Cancer (2005) 93, 1395-1399.
18) Albaugh GP, Iyengar V, Lohani A, Malayeri M, Bala S, Nair PP : Isolation of exfoliated colonic epithelial cells, a novel, non-invasive approach to the study of cellular markers. Int J Cancer (1992) 52, 347-350.
19) 大腸癌治療ガイドライン医師用2005年度版, 大腸癌研究会編, 金原出版, 東京(2005).
言語
Japanese
OAI-PMH Set
岡山大学
著作権者
岡山医学会
論文のバージョン
publisher
査読
有り
DOI
Sort Key
3
Eprints Journal Name
joma